STEATOHEPATITIS, NONALCOHOLIC

Clinical trials for STEATOHEPATITIS, NONALCOHOLIC explained in plain language.

Never miss a new study

Get alerted when new STEATOHEPATITIS, NONALCOHOLIC trials appear

Sign up with your email to follow new studies for STEATOHEPATITIS, NONALCOHOLIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Malaria drug trial offers hope for millions with fatty liver disease

Disease control Recruiting now

This study is testing whether hydroxychloroquine, a drug used for malaria and arthritis, can help treat fatty liver disease with inflammation. 210 adults with confirmed fatty liver and elevated liver enzymes will take either the drug or a placebo pill daily for one year. Research…

Matched conditions: STEATOHEPATITIS, NONALCOHOLIC

Phase: PHASE3 • Sponsor: National Taiwan University Hospital • Aim: Disease control

Last updated Mar 27, 2026 12:41 UTC

STEATOHEPATITIS, NONALCOHOLIC

Get alerted when new STEATOHEPATITIS, NONALCOHOLIC trials appear

Malaria drug trial offers hope for millions with fatty liver disease